HeraMED Limited (HMD.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -6.42 Million AUD | -45.53% |
| 2022 | -4.58 Million USD | 12.57% |
| 2021 | -5.24 Million AUD | -4.69% |
| 2020 | -5.01 Million AUD | -7.88% |
| 2019 | -4.64 Million AUD | -61.64% |
| 2018 | -2.87 Million AUD | -242.72% |
| 2017 | -838.86 Thousand AUD | 69.08% |
| 2016 | -2.71 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -3.15 Million AUD | 0.0% |
| 2023 Q2 | -3.22 Million AUD | 0.0% |
| 2023 FY | -6.67 Million AUD | -45.53% |
| 2023 Q4 | -3.45 Million AUD | 0.0% |
| 2022 Q2 | -2.06 Million AUD | 0.0% |
| 2022 Q4 | -2.53 Million AUD | 0.0% |
| 2022 FY | -4.58 Million USD | 12.57% |
| 2021 FY | -5.24 Million AUD | -4.69% |
| 2021 Q4 | -2.98 Million AUD | 0.0% |
| 2021 Q2 | -2.27 Million AUD | 0.0% |
| 2020 Q4 | -2.78 Million AUD | 0.0% |
| 2020 FY | -5.01 Million AUD | -7.88% |
| 2020 Q2 | -2.19 Million AUD | 0.0% |
| 2019 FY | -4.64 Million AUD | -61.64% |
| 2019 Q4 | -2.55 Million AUD | 0.0% |
| 2019 Q2 | -2.09 Million AUD | 0.0% |
| 2018 Q4 | -1.11 Million AUD | 0.0% |
| 2018 FY | -2.87 Million AUD | -242.72% |
| 2018 Q2 | -1.01 Million AUD | 0.0% |
| 2018 Q1 | -1.01 Million AUD | 0.0% |
| 2017 FY | -838.86 Thousand AUD | 69.08% |
| 2017 Q4 | -1.01 Million AUD | 0.0% |
| 2016 FY | -2.71 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 77.015% |
| Adherium Limited | -11.98 Million AUD | 46.368% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 34.326% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -47.381% |
| Anteris Technologies Ltd | -66.63 Million AUD | 90.353% |
| Control Bionics Limited | -5.92 Million AUD | -8.411% |
| CardieX Limited | -4.63 Million AUD | -38.722% |
| Compumedics Limited | -269 Thousand AUD | -2289.586% |
| Cochlear Limited | 521.5 Million AUD | 101.233% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -33.528% |
| Cyclopharm Limited | -9.22 Million AUD | 30.317% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -298.163% |
| Nova Eye Medical Limited | -3.79 Million AUD | -69.291% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 63.426% |
| ImpediMed Limited | -19.03 Million AUD | 66.232% |
| InhaleRx Limited | -1.38 Million AUD | -363.617% |
| LBT Innovations Limited | -4.74 Million AUD | -35.612% |
| Micro-X Limited | -13.02 Million AUD | 50.656% |
| Neurotech International Limited | -5.58 Million AUD | -15.098% |
| OncoSil Medical Limited | -11.98 Million AUD | 46.363% |
| PolyNovo Limited | 1.16 Million AUD | 652.707% |
| Respiri Limited | -7 Million AUD | 8.174% |
| SomnoMed Limited | -3.84 Million AUD | -67.339% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 61.464% |
| Uscom Limited | -2.4 Million AUD | -167.348% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -9.803% |